Food allergy in children with atopic dermatitis is associated with an increased risk for asthma, allergic rhinitis, and ...

Regeneron Pharmaceuticals ... It also provides Dupixent injection to treat atopic dermatitis and asthma in adults and pediatrics; Libtayo injection to treat metastatic or locally advanced ...

Lilly’s drug becomes an oral alternative to Sanofi and Regeneron’s biologic therapy ... a second-line option for moderate to severe atopic dermatitis in 2018. Both drugs should be used only ...

In Singapore, Dupixent is the first biologic medicine approved to treat these COPD patients. The prevalence of COPD is estimated to be around 6% of the general population [1], and it ranks as a ...

Johnson & Johnson has reached an agreement to acquire a bispecific antibody for atopic dermatitis (AD ... that the drug shares with Sanofi and Regeneron’s blockbuster AD therapy Dupixent ...

Slow progress, pipeline uncertainty & lack of catalysts weigh despite strong cash. Click to read why KYMR stock is a Hold.

Atopic dermatitis—the most common type of eczema—can look very different on darker skin tones. As someone living with the ...

Two studies explored the quality-of-life impacts of lebrikizumab for atopic dermatitis, finding its benefits extend beyond ...

Researchers reported key differences in atopic dermatitis presentation across racial groups and steps clinicians can take to ...

Patients with atopic dermatitis had an increased risk for COVID-19 infection despite age and sex, and some comorbidities were linked to a greater risk.